NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Link Therapeutics, Inc.

Private
KyotoHealthcare & Life Sciences

Last Round

Series B

Jul 18, 2025

Total Funding Raised

$7.82M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Link Therapeutics, Inc. is a biotechnology company that develops treatment methods designed for targeting and searching for pathogenic auto-antibodies.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine

Business Model

B2B

Customer Profile

Revenue Share

AI Layer

Non-AI

Keywords

autoantibody removalautoimmune disease therapyanti-integrin αvβ6 antibodyulcerative colitis therapyantibody therapytargeted therapypreclinical biotechprimary sclerosing cholangitisdrug discoverypharma licensingintegrin αvβ6therapeutic platformuniversity spin-out

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Link Therapeutics, Inc. Comparables

Compare Link Therapeutics, Inc. with similar companies based on industry and business-model similarity.

Link Therapeutics, Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap

View Full Comparables Set

Access detailed peer comparisons, similarity scores, and market data.

Link Therapeutics, Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series BJul 18, 2025
Series AFeb 28, 2023

Link Therapeutics, Inc. Investors

Notable investors and investment history

Link Therapeutics, Inc. investors
InvestorRounds
ITOCHU Technology VenturesSeries B
Kobe University CapitalSeries B
Mitsubishi UFJ CapitalSeries A
ITOCHU Technology VenturesSeries B
Kyoto University Innovation CapitalSeries A, Series B
SMBC Venture CapitalSeries A, Series B

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 18, 2025

    $6M round with ITOCHU Technology Ventures and SMBC Venture Capital.

Link Therapeutics, Inc. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Link Therapeutics, Inc. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Link Therapeutics, Inc.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersKyoto
Year Founded2022
Last FundingJul 18, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.